We found that sparse and confluent C6 glioma cells differ both in GM3 conte
nt, which increases with cell density, and in endothelin-1 (ET-1)-induced p
hosphoinositide hydrolysis, which was markedly higher in the sparse cells t
han in the confluent. Also after manipulation of the cellular GM3 content t
hrough treatment with exogenous GM3 or with drugs known to affect GM3 metab
olism, the ET-I effect was inversely related to GM3 cellular levels. Cell t
reatment with an anti-GM3 mAb resulted in the enhancement of ET-1-induced p
hospholipase C activation and restored the capacity of GM3-treated cells to
respond to ET-1. These findings suggest that the GM3 ganglioside represent
s a physiological modulator of ET-1 signaling in glial cells. (C) 2001 Publ
ished by Elsevier Science B.V. on behalf of the Federation of European Bioc
hemical Societies.